Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02649465
What this trial is testing

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Kanazawa University 40
Early research (Phase 1)WithdrawnNCT02457286
What this trial is testing

Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Northwell Health
Not applicableStudy completedNCT04509245
What this trial is testing

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver, Nonalcoholic
German Diabetes Center 24
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Not applicableStudy completedNCT02461212
What this trial is testing

Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth

Who this might be right for
Non-alcoholic Fatty Liver Disease
Emory University 50
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Testing effectiveness (Phase 2)WithdrawnNCT05118360
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gannex Pharma Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT04475276
What this trial is testing

Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases

Who this might be right for
Non-Alcoholic Fatty Liver Disease
All India Institute of Medical Sciences, Bhubaneswar 120
Very early researchStudy completedNCT06681597
What this trial is testing

Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans

Who this might be right for
ObesityDiabetesNAFLD (Nonalcoholic Fatty Liver Disease)
Nanchang University 60
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Post-approval studies (Phase 4)Active Not RecruitingNCT05147090
What this trial is testing

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis bNAFLDCirrhosis+3 more
The University of Hong Kong 106
Not applicableActive Not RecruitingNCT06354491
What this trial is testing

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

Who this might be right for
NAFLDNASH
University of Wisconsin, Madison 24
Not applicableStudy completedNCT01556113
What this trial is testing

Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver DiseaseSteatohepatitisHypertriglyceridemia+1 more
Yale University 17
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Not applicableUnknownNCT01927133
What this trial is testing

LIVER FIBROSIS PREVALENCE IN FRANCE

Who this might be right for
Liver Fibrosis Progression in Chronic Liver Disease
Assistance Publique - Hôpitaux de Paris 10,000
Testing effectiveness (Phase 2)Study completedNCT04080947
What this trial is testing

The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Steatohepatitis, Nonalcoholic
Sadat City University 56
Large-scale testing (Phase 3)UnknownNCT02530138
What this trial is testing

The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 42
Not applicableStudy completedNCT02231333
What this trial is testing

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 122
Not applicableStudy completedNCT02267148
What this trial is testing

Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression

Who this might be right for
Non-alcoholic Fatty Liver Disease
UNC Nutrition Research Institute 53
Next Page